N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Intermediate High Purity
Samar da Kasuwancin Imatinib Mesylate da Matsakaici masu alaƙa:
Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl) pyrimidin-2-amine CAS: 152460-09-8
N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride CAS: 106261-49-8
Sunan Sinadari | N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea |
Makamantu | Imatinib Mesylate Intermediate;2- (5-Amino-2-methylanilino) -4- (3-pyridyl) pyrimidine |
Lambar CAS | 152460-10 |
Lambar CAT | Saukewa: RF-PI230 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | C16H15N5 |
Nauyin Kwayoyin Halitta | 277.32 |
Matsayin narkewa | 133.0-135.0 ℃ |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Orange Haske zuwa Foda Jawo zuwa Crystal |
Tsarkake / Hanyar Bincike | ≥98.0% |
Asara akan bushewa | ≤0.50% |
Ragowa akan kunnawa | ≤0.50% |
Jimlar ƙazanta | ≤2.0% |
Matsakaicin Tsabtace Guda Daya | ≤1.0% |
Karfe masu nauyi | ≤20ppm |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin Imatinib Mesylate (CAS: 220127-57-1) |
Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.
Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai samar da N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea (CAS: 152460-10-1) tare da babban inganci. .
N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea (CAS: 152460-10-1) matsakaici ne yawanci a cikin kirar Imatinib Mesylate (CAS: 220127-57-1) ) API.
Imatinib mesylate wani ƙananan ƙwayoyin cuta ne wanda ke hana c-Abl protein-tyrosine kinase, kinase mai mahimmanci musamman don yaduwar cutar sankarar jini na myelogenous (CML).Wani lamari mai canzawa tsakanin chromosomes 9 da 22 yana haifar da chromosome na Philadelphia, wanda sannan ya samar da furotin Bcr-Abl fusion tare da aikin kinase mai banƙyama wanda ke inganta yaduwar kwayar halitta.Imatinib mesylate yana ɗaure wannan mahimmancin kinase, yana dakatar da haɓakar CML.An ƙara nuna Imatinib mesylate don hana PDGFR da tyrosine kinases masu alaƙa da c-Kit.An yi amfani da nau'ikan da ke ɗauke da Imatinib mesylate don magance cututtukan daji daban-daban.
Imatinib mesylate shine mai hana tyrosine kinase.Musamman musamman ga BCR-ABL, enzyme da ke hade da cutar sankarar myelogenous na yau da kullun (CML) da wasu nau'ikan cutar sankarar lymphoblastic mai tsanani (ALL).V-Abl tyrosine kinase inhibitor ne mai ƙarfi da zaɓi (IC50 = 38 nM).Hakanan yana hana PDGFR da c-kit.Yana nuna zaɓi don v-Abl akan rukunin sauran tyrosine da serine/threonine protein kinases.Zaɓin ya hana PDGF-ƙarfafa haɓakar ƙwayoyin PB-3 da aka canza v-abl da sel BALB/c 3T3 da aka canza a cikin vitro.Yana nuna tasirin antitumor a cikin beraye masu ɗauke da AMuLV ko sel BABL/c 3T3 v-sis.Yana hana kwafin SARS-CoV da MERS-CoV a cikin vitro (ƙimar EC50 sune 9.823 da 17.689 μM, bi da bi).